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a b s t r a c t
In the current cardiac device implantation practice, screw-in leads are important for stability of atrial
and ventricular pacing. There are two screw-in leads, the Sweet Tip™ and the retractable screw-in lead;
both are widely used. The difference between them is the exposure of the helix during placement. The
Sweet Tip lead has an exposed screw covered with mannitol to prevent undesirable entrapment or
perforations before ﬁxation. The mannitol melts within several minutes, after which direct ﬁxation is
feasible. The Sweet Tip™ has a simple mechanical structure, which facilitates ﬁxation. This review
emphasizes the usefulness of the Sweet Tip™ screw-in lead and suggests how to apply it safely.
& 2014 Published by Elsevier B.V. on behalf of Japanese Heart Rhythm Society.
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1. Introduction
Since the implantable cardiac pacemaker was ﬁrst introduced
into clinical practice, various developments have been achieved in
both generator and lead systems. In particular, the pacing lead is
the most important part of a pacing system, because it should be
functional throughout a patient's life, unless unexpected problems
are encountered. Therefore, a high-quality lead is required to
ensure longevity, safety, stability, and good electrical performance.
The ﬁrst experimental studies on the transvenous endocardial
screw-in lead were published in 1971 in Japan by Abe et al. [1]. Six
years later, the ﬁrst clinical experiences with the transvenous
screw-in lead were described by Kleinert and Bisping [2]. With the
introduction of the screw-in lead system, atrial pacing has become
feasible, and the incidence of dislodgment was dramatically
reduced [3,4]. The initial concern with the screw-in lead system
was the rise in acute and subacute thresholds; however, the use of
the steroid tip has overcome this problem [5,6]. Recently, right
ventricular apical pacing was reported to be harmful because it
impaired left ventricular function due to a dyssynchronous move-
ment: consequently, the indications for ventricular septal pacing
with screw-in leads have increased in an effort to provide a
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hemodynamic advantage [7,8]. Thus, the screw-in lead has
become indispensable in current device implantation practice.
On the other hand, the risk of cardiac perforation has been
sporadically reported, which might discourage some surgeons
from using the screw-in leads [9]. However, the causes of perfora-
tion might be largely attributed to the implanting technique used
by the surgeon, not to the actual device. Therefore, we suggest
methods for safely using the Sweet Tip™ type screw-in lead.
2. Historical overview
Before the development of screw-in leads, several types of non-
screw pacing leads were designed to passively attach to the heart
muscle with tips of different shapes, including straight, fringed,
ﬁnned, or tined. However, a high incidence of dislodgement was a
major concern, and it currently remains a routine complication.
In particular, for atrial pacing, the right atrial appendage is the
only feasible ﬁxation position with non-screw leads. Thus, the
surgeon has no alternative, even when the pacing threshold is
unacceptably high. Often, the result is to abandon atrial pacing.
This problem may be resolved with the introduction of the screw-
in lead. The screw-in lead provides high stability, and re-ﬁxation is
possible at any site when the electrical parameters at the initial
position are unacceptable. Additionally, the hemodynamic impor-
tance of the atrial contribution was recently recognized. This has
emphasized the importance of atrioventricular synchronous
pacing [10]. Thus, stable atrial pacing has become indispensable,
and the use of the screw-in lead has spread rapidly. Furthermore,
recent studies have demonstrated that right ventricular apical
pacing can prolong the QRS width, which results in a deterioration
of cardiac function due to increased inter-ventricular dyssyn-
chrony [7]. Those results led to the recommendation that right
ventricular septal pacing should be preferred because it preserves
a narrow QRS, and thus, apical pacing is currently avoided. Septal
pacing is only possible with the screw-in lead. Thus, indications for
the screw-in lead have increased, and it has become an essential
tool for both atrial and ventricular pacing practice.
3. Classiﬁcation of the screw-in lead
Currently, screw-in leads are available in two types of designs.
One is the retractable screw-in lead and the other is the Sweet
Tip™ (Fig. 1A and B). The name “Sweet Tip™” is a trade mark of
Boston Scientiﬁc Corp., Natick, MA, USA (Sweet Tip™ Rx). In this
review, a ﬁxed helix type of lead coating with mannitol is
described as Sweet Tip™. The retractable type features the ability
to store the helix within an insulating tube at the tip. Then, by
applying torque to the end of the connector several times, the
helix protrudes from the tip, and it can be screwed into cardiac
tissue. The Sweet Tip™ comprises a helix covered with mannitol
[5]. After insertion, the mannitol melts within 3–5 min at body
temperature; thus, the helix is exposed once it is correctly placed
in the heart, just before ﬁxation. Once the helix is in contact with
the target, it can be ﬁxed by turning the lead body clockwise
several times to screw it into the cardiac tissue. Before the
development of the Sweet Tip™ lead, only an “exposed” helix
type lead was available. Its use was associated with the risks of
entrapment in the venous system when en route to the target area
or perforations before reaching the right atrium. To avoid these
complications, the mannitol coating was developed. The current
Sweet Tip™ lead is available in two helix lengths, 1.5 mm and
1.6 mm. Both the retractable and Sweet Tip™ leads are designed
with a bipolar conﬁguration to include a steroid eluting system. In
addition, the lead insulation is available in both silicon and
polyurethane. More details on the differences between lead types
are presented elsewhere. Before the implantation procedure,
surgeons should be aware of the lead characteristics; the combi-
nation of tip design, insulation materials, and helix length confer
differences in stiffness and maneuverability. It is important that
the operator understands both the electrical and mechanical
characteristics of the lead to avoid the occurrence of adverse
complications, including cardiac perforation, during the implanta-
tion procedure.
4. Retractable or Sweet Tip™?
The screw-in lead provides high stability in both atrial pacing
and ventricular pacing. The surgeon can choose to use either the
retractable or Sweet Tip™ type lead based on preference. Con-
sidering lead maneuverability, the Sweet Tip™ lead has a simple
mechanical structure, and it is easy to ﬁx because it only requires
rotating the lead body several times. After the mannitol has
melted, the ﬁxation procedure can be performed in a single
manipulation step. In contrast, the retractable lead ﬁxation
requires multiple steps: ﬁrst, the tip must be pushed out to the
myocardial wall while holding it in position and second, torque
must be applied with a pinching tool from the connector end to ﬁx
the screw. These steps compromise the smoothness of the proce-
dure and increase the risk of dislodgement. In addition, the
mechanical structure of the retractable leads is relatively compli-
cated, and the storage tube for the screw is relatively stiff. These
properties have elicited some concerns about its durability and
about the risk of perforation during the procedure. Based on these
observations, the author recommends the Sweet Tip™ type over
the retractable type of screw-in lead.
5. Electrical characteristics of the Sweet Tip™ screw-in lead
It is common that the pacing threshold increases mildly
because of tissue injury, immediately after a screw-in lead is ﬁxed
on the atrium or ventricle, i.e., during the acute phase of ﬁxation.
However, if the measured threshold value is exceedingly high, the
lead position should be changed immediately, without hesitation.
In our experience, in the former cases, the thresholds improve
after several minutes; therefore, we recommend waiting for
approximately 5 m. In these cases, long-term results are also
Mannitol
Fig. 1. (A) Retractable type and (B) Sweet Tip™ type.
Y. Nakazato / Journal of Arrhythmia 30 (2014) 88–91 89
favorable. Thus, frequent changes in lead position are not always
necessary [11].
6. Practical use of the Sweet Tip™ screw-in lead
6.1. Atrial ﬁxation
The greatest difference between the screw-in and non-screw
lead system is the selectivity of the ﬁxation site. For example, the
tined lead can only be ﬁxed in the right atrial appendage, but the
screw-in lead can be applied anywhere on the atrium. When the
initial ﬁxation site is unacceptable, the screw-in lead can be easily
moved to another ﬁxation position. To prevent complications
during the procedure, it is preferable to avoid the atrial free wall,
because it is thin, and disturbances often cause phrenic nerve
stimulation. The curve of the stylet is also key for successful
ﬁxation. When aiming for the lower atrium, a stylet with a
relatively wide-angle J curve is desirable. When aiming for the
upper atrium, a stylet with a small, acute-angle J curve is
recommended for stable ﬁxation. Once the tip of the screw-in
lead comes into contact with the target position, the lead tip
should be pushed very gently, and the lead body should be rotated
clockwise 5 times. The lead should never be pushed forcefully or
rotated excessively. However, surgeons with less experience often
tend to underestimate the turns required for ﬁxing the screw,
because their main concern is a perforation, but a loose attach-
ment may result in early dislodgement. We recommend less
experienced surgeons to give 1 or 2 additional rotations. Typically,
the screw will spontaneously return to the standard position after
the surgeon releases the lead. Then, the stylet should be pulled
slowly and carefully to shape the lead curve appropriately. When
acceptable pacing and sensing thresholds can be obtained at the
initial position, the procedure is complete. Otherwise, the lead can
be unscrewed by rotating it counterclockwise the correct number
of times, and then the lead can be moved to another target
position. The merit of the Sweet Tip™ lead is its feasibility for
relocation by simple steps.
6.2. Ventricular ﬁxation
If the target position is the apex of the heart, the technique is
not different when inserting tined leads until they reach the apex.
The lead is inserted into the atrium, the stylet should form a large,
slack curve, and it should be advanced towards the apex. When
the lead has moved through the tricuspid valve, care should be
taken to prevent lead entrapment. In particular, when the manni-
tol melts from the Sweet Tip™ in the atrium, the exposed helix has
an increased risk of entrapment. Once the lead tip reaches the
apex, the ﬁxation method is basically the same as mentioned
above. To prevent perforation, gentle manipulation is required.
Recently, to improve the cardiac hemodynamics, the ventricu-
lar ﬁxation position was shifted from the right ventricular apex to
the septum. It is still controversial whether septal pacing is
superior to apical pacing. In the European Society of Cardiology
2013 guidelines, the Task Force commented that a deﬁnite recom-
mendation not be given until the results of larger trials become
available [12]. However, to obtain a narrow QRS complex, the
pacing site should be the ventricular septum, and the screw-in
lead is the only lead type suited for this purpose. In particular, the
Sweet Tip™ screw-in lead is ideal, because it has excellent
maneuverability. From a technical viewpoint, the curve of the
stylet should be relatively acute and small compared to that used
in the typical apical approach. This preshaped stylet should be
advanced for several cm. Then, the lead tip should be initially be
introduced into the right ventricular septum at a high point.
Subsequently, the lead tip should be moved to a mid-to-low
septum position. When this procedure produces a narrow QRS
extra systole, the lead body should be rotated 4 to 6 times with
gentle pressure to ﬁx the lead. It is important to achieve a narrow
QRS complex, regardless of the anatomical position. Once the
appropriate ﬁxation is conﬁrmed, the stylet should be removed so
that the desirable lead conﬁguration can be achieved. However,
when the electrical measurements are unacceptable, the lead tip
should be moved toward the lower septum to locate a position
that achieves a narrow QRS complex. Because cardiac dimensions
vary in each patient, the curve of the stylet in the atrium or
ventricle might have to be altered to suit the individual. However,
the basic technique remains the same. Gentle, careful manipula-
tion is the key to successful and safe ﬁxation of a Sweet Tip™ lead.
7. Entrapment of screw-in lead
Entrapment is a relatively rare complication that can occur
with the Sweet Tip™ screw-in lead as often as with other types of
leads [13,14]. In the Sweet Tip™ lead, the helix might become
exposed in the atrium and the risk of entrapment may be higher
than the risk with a retractable lead. The most common entrap-
ment site is the tricuspid valve, but it also rarely occurs in the
vessels, the atrial wall, and intra-cardiac remnant tissues. To
prevent entrapment, it is important to apply gentle manipulation
and counterclockwise rotation to navigate through the tricuspid
valve. The stylet is pulled for several cm to make a loop in the
atrium, and then the lead is advanced from the middle of the loop
side into the ventricle. After introducing the lead into the ventricle,
the loop is released by moving the stylet and directing the lead tip
to the desired position. If the lead has become entrapped in the
tricuspid valve, it should not be moved forcefully, but gently, with
counter-clockwise rotations. If repeated trials are not effective, the
surgeon should consider either leaving the lead in place or
removing it surgically, depending on the patient's background.
The author's experiences have been similar to the case described
by Maruyama et al. [14], where the entrapped lead could only
sense the atrial electrical signals and it was used as an atrial
sensing lead with a DDD pacemaker in a patient with atrioven-
tricular block. In similar cases, adapting to the circumstances is
necessary.
8. Conclusion
The Sweet Tip™ type of screw-in lead has superior maneuverability
compared to other types of screw-in leads. The Sweet Tip™ screw-in
lead is feasible and safe for application in both atrial and ventricular
pacing, when the surgeon is familiar with the lead characteristics.
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